Meta description: What is the Success Rate of TMS? Discover powerful response and remission rates for treatment-resistant depression and OCD with TMS therapy.
For people with hard-to-treat depression, TMS therapy often works where medications don’t. The numbers tell the story: about half to 60% of patients see a meaningful response, and roughly 30% achieve full remission.
At our clinic, we use FDA-cleared NeuroStar TMS as part of a bigger plan for long-term wellness, not just symptom relief. Newer protocols are pushing these results even higher.
If you’ve tried other treatments without success, this approach might be different. Read on to see how modern neuromodulation is changing care for depression and OCD.
Key Takeaways
- TMS shows 50-60% depression response rates
- NeuroStar reports 83% response, 62% remission
- FDA-cleared, noninvasive outpatient treatment
Understanding TMS Success Rates
Let’s talk about how doctors know if TMS is working. They look for two big signs: “response” and “remission.”
A “response” means a patient feels about half as bad as they did before treatment. Doctors use checklists, like the PHQ-9, to measure this. “Remission” is the real win. It means the patient’s depression symptoms are so low they don’t really get in the way of daily life anymore.
In our daily practice at Weston Psychological Associates, we don’t just chase symptom reduction, we aim for full remission.
Our clinical experience echoes what researchers at UCLA have documented: leaving even a lingering trace of residual fatigue or low mood significantly increases a patient’s risk of relapse.
By tracking our patients’ progress weekly using the PHQ-9 scale, we tailor the magnetic stimulation dynamically to ensure we are thoroughly clearing those stubborn, final symptoms rather than settling for a partial recovery
Here’s what the numbers usually look like in TMS studies:
| Metric | Definition | Typical Outcome |
| Response Rate | At least 50% reduction in depression symptoms | 5060% of patients |
| Remission Rate | Symptoms become minimal or absent | About 30% of patients |
| Clinical Improvement | Significant symptom relief without full remission | Over 57% of patients |
| Non-Responder Rate | Limited or no measurable improvement | Around 40% of patients |
Why does this matter? Because getting better isn’t always all-or-nothing. A patient might not hit “remission,” but if they can sleep through the night, stop thinking about suicide, focus at work, and get back to their life, that’s still a huge success.
TMS Outcomes in Treatment-Resistant Depression
Medications don’t work for everyone. For patients exploring candidates for NeuroStar TMS therapy after multiple unsuccessful antidepressant trials, that’s often the reality. Each failed prescription can feel like another door closing.
Data from National Institutes of Health demonstrates
“there was a 79.4% response and 60.3% remission rate” – National Institutes of Health
TMS therapy opens a different door. It uses magnetic pulses to target a key brain area for mood, the left dorsolateral prefrontal cortex. Think of it as a gentle, direct stimulation.
The goal is to encourage the brain’s own networks to reset and communicate better. It’s not a drug, so it avoids the systemic side effects that pills often bring.
The clinical outcomes are encouraging. In real world use, patients who complete therapy with devices like NeuroStar often see improvement. Response rates hover around 83 percent.
Remission rates are about 62 percent. Even for those with four or more prior medication failures, studies show a solid response. It works because it addresses the problem at its source.
In our clinic, we integrate TMS with other evidence based treatments. Psychotherapy, medication review, neurofeedback. This whole person approach lets us customize care and monitor progress closely.
The outpatient process is straightforward: patients attend a brief office session without the need for anesthesia or the risk of subsequent cognitive fog.
This allows individuals to immediately return to their daily routines while the therapy actively works to lift the burden of severe symptoms, including crushing fatigue, pervasive anxiety, and a deep sense of hopelessness
Complete remission isn’t guaranteed for every person. But meaningful change is a realistic goal. For many, it’s the first real progress they’ve seen in a long time.
Comparing Success Rates Across TMS Protocols
TMS therapy is advancing. While modern neuromodulation is advancing, not all new protocols target higher efficacy; some prioritize efficiency.
For instance, Theta Burst Stimulation yields response and remission rates highly comparable to standard rTMS, but its true breakthrough lies in drastically shortening session times for the patient
In our clinic, we frequently evaluate patients for newer protocols like Deep TMS, which utilizes specialized H-coils to safely penetrate deeper, broader neural networks, and accelerated theta burst stimulation, which drastically shortens session times without sacrificing clinical efficacy.
Here is a look at how they compare.
| TMS Protocol | Reported Response Rate | Reported Remission Rate | Key Characteristics |
| Standard rTMS | About 50% | About 30% | Traditional FDA-cleared protocol targeting the left prefrontal cortex |
| Deep TMS | About 82% | About 65% | Uses H-coil technology to stimulate deeper brain regions |
| Theta Burst Stimulation | Similar to standard rTMS | Similar to standard rTMS | Shorter treatment sessions with faster delivery |
| SAINT Protocol | About 86% | About 79% | Accelerated high-frequency protocol guided by brain imaging |
Deep TMS uses a different coil design. An H coil. It aims to stimulate deeper structures linked to mood disorders. Data from trials is solid. Good response after twenty to thirty sessions.
The SAINT protocol is different. It’s fast. Stanford developed it. It uses high frequency theta bursts guided by detailed brain imaging.
Treatment is compressed into days, not weeks. Early results are impressive. Remission rates near eighty percent. We need more data, but it’s promising.
Clinics frequently utilize NeuroStar technology due to its extensive clinical trial database and robust safety profile, which provide a reliable foundation when integrating neuromodulation into broader psychiatric care plans.
However, selecting a neuromodulation protocol is a highly individualized medical and financial decision.
Because TMS requires a commitment of five days a week for six weeks, our clinical team works directly with patients during the initial psychiatric assessment to break down the total TMS therapy cost, navigate insurance pre-authorization requirements, map out potential out-of-pocket expenses, and ensure the treatment schedule aligns with their daily life.
It depends on the patient’s symptom severity. Their history of medication failures. Whether they have anxious depression or OCD.
Their neurological background. The Mayo Clinic notes TMS is gaining ground because it’s noninvasive. And for patients who don’t tolerate pills, that’s critical.
So the technology is improving. But the principle remains. Match the tool to the individual. That’s the real art of it.
Duration of Results After TMS Therapy
The benefits of TMS often stick around. Patients can feel better for a long time after their initial treatment course. Months, sometimes years.
But depression is a recurring condition. Without a structured maintenance plan, symptoms can return. Research gives us a clear picture. About two thirds of patients maintain their improvement for one full year.
Yet, studies also indicate relapse is common. Roughly half of patients may experience it within twelve months if there is no ongoing management.
A maintenance strategy is crucial. It typically combines several elements. Periodic TMS booster sessions. Continued psychotherapy.
Medication adjustments as needed. And consistent psychiatric follow up. Most relapses occur early, within the first several months post treatment.
For individuals with recurrent major depressive disorder, long term monitoring is not just beneficial. It’s often necessary. Early intervention when symptoms re emerge can make a significant difference.
In our clinic, we view the initial treatment response as just the first step. We integrate maintenance planning into the overall care strategy from the start.
This involves close outcome tracking and adapting the plan based on the patient’s journey. Because sustained wellness is the ultimate goal.
Typical Timeline for Symptom Improvement During TMS
While response timelines vary, early signs of neurological shifting often appear within the first two weeks (sessions 3 through 8).
Patients typically notice secondary improvements first, such as sharper concentration and normalized sleep patterns, before the deeper, core feelings of depression begin to fully lift toward the end of the six-week course
The emotional numbness begins to thaw. But the deeper mood improvement, the real lifting of that weight, often comes later. Toward the end.
This gradual nature is key. It reflects how TMS actually works. The repetitive stimulation encourages the brain’s networks to change.
To rewire their connections. It’s a process that takes time, unlike the immediate chemical shift of a pill.
And because TMS therapy in Weston is noninvasive, requiring no anesthesia, life doesn’t stop during treatment. Patients leave our office and go right back to their day. To work, to class, to their family. Immediately.
Factors That Affect TMS Treatment Outcomes
Everyone responds differently to TMS therapy. It isn’t a uniform process.
The final outcome hinges on several moving parts: the specific treatment protocol, how consistently a patient attends sessions, their neurological makeup, and how severe their depression is.
No single TMS approach works the same for everyone.
Why? Because clinical response depends on a web of interacting factors. A patient’s underlying neurobiology, their psychiatric history, the precision of the treatment delivery. All of it matters.
Several clinical variables directly influence treatment success:
- Coil Placement Precision: Accurately targeting the left dorsolateral prefrontal cortex ensures consistent structural stimulation.
- Dosing Intensity: Tailoring the magnetic pulse intensity to the patient’s specific motor threshold rather than using a fixed variable.
- Psychiatric Comorbidities: Managing concurrent diagnoses, such as OCD, anxiety disorders, or bipolar depression, which can alter the brain’s baseline responsiveness
The technology itself matters. Deep TMS coils, called H coils, stimulate broader cortical networks than the standard figure eight coils.
And a patient’s neurological history sets boundaries. Seizure disorders, certain implants. These may limit eligibility for the treatment altogether.
At Weston Psychological Associates, we build the treatment plan around these variables. It begins with a thorough psychiatric assessment. We track symptoms closely.
We adjust the protocol individually throughout the entire course. Our cloud based treatment management systems support this. They allow for precise dosing, real time feedback, and ongoing clinical monitoring.
Limitations and Non-Response in TMS Therapy
TMS therapy doesn’t work for everyone. Some patients finish the full course and only see a partial improvement in their symptoms.
In fact, most clinical data shows that about 40% of people might not get a significant clinical response from it.
Research from The BMJ shows:
“summary odds ratio of 3.17 (95% confidence interval 2.29 to 4.37)” –The BMJ
This kind of variability is actually common across nearly all psychiatric treatments. It happens with antidepressant medications and even with psychotherapy.
There are several clear limitations that affect who can get TMS and how well it works for them.
First, safety. We cannot safely treat patients who have certain metallic implants near their head. This includes some cochlear implants and deep brain stimulators.
Second, approval. NeuroStar TMS is only FDA-cleared for specific conditions. These are Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), and anxious depression.
Third, appropriateness. TMS is generally not considered a first-line treatment for mild depression.
If a patient’s mild depression is already successfully controlled through medication alone, TMS likely isn’t the right next step.
Fourth, neurological risk. Certain conditions that involve a higher seizure risk may mean a patient is excluded from treatment, or they may require a very specialized evaluation before we proceed.
Fifth, age. Using TMS for pediatric patients under the age of 15 requires careful psychiatric supervision. It demands an individualized clinical review for each case.
On the side effect front, some patients do experience temporary scalp discomfort or a mild headache during their treatment sessions.
However, serious adverse events remain rare, provided the standard safety protocols are followed.
Why is there so much outcome variability? It reflects real differences in a person’s brain circuitry, how long their illness has lasted, the severity of their treatment resistance, and the specific TMS protocol we select.
Because of this, psychiatrists typically frame TMS as a clinically validated treatment option. It’s a powerful tool, but it is not a guaranteed cure.
TMS Can Open a New Path When Depression Still Won’t Let Up
When depression keeps coming back even after trying medication, it can leave you drained and frustrated. That’s the hard part. TMS gives some patients a real option without the weight gain, fatigue, or other side effects that often come with medication.
At Weston PA, treatment goes beyond one approach. Their team combines FDA-cleared NeuroStar TMS with therapy and psychiatric support to help patients find a plan that actually fits their needs. If symptoms continue despite medication, Weston PA may be a helpful next step worth considering.
Ready to explore whether TMS is right for you? Visit Weston Psychological Associates to learn more or schedule a consultation with their team.
FAQ
Can TMS help patients after several antidepressants stop working?
Many patients with treatment-resistant depression pursue transcranial magnetic stimulation after multiple antidepressants fail to provide lasting symptom relief. This noninvasive treatment uses repetitive magnetic pulses to stimulate brain circuits involved in mood regulation.
Clinical studies report strong clinical response and remission rates in medication resistant depression. An individualized TMS protocol may improve depression relief, treatment outcomes, and overall mental wellness without requiring additional psychiatric medication.
How long does a complete TMS treatment course usually last?
A standard rTMS therapy treatment course usually includes daily sessions over four to six weeks. Most outpatient procedures target the left dorsolateral prefrontal cortex using magnetic stimulation and a specialized magnetic coil.
Some clinics also use intermittent theta burst stimulation, which shortens each TMS session while maintaining treatment efficacy. The full therapy course length depends on symptom severity, clinical response, and the patient’s individualized treatment plan.
Are TMS side effects milder than traditional depression treatment options?
Most patients tolerate transcranial magnetic stimulation well because the procedure does not require anesthesia or systemic medication exposure. Common side effects include temporary scalp discomfort, mild headaches, or facial muscle twitching during magnetic stimulation.
Unlike many antidepressant alternatives, this noninvasive depression therapy usually does not cause weight gain, sexual dysfunction, or daytime sedation. Its favorable safety profile supports wider use in psychiatric care and modern neuropsychiatry practices.
Can TMS also improve anxiety symptoms or OCD treatment outcomes?
Clinical studies suggest that deep TMS and other neuromodulation approaches may improve anxiety symptoms, OCD treatment outcomes, and bipolar depression symptoms in some patients. This magnetic brain treatment supports neural plasticity and targets brain circuits associated with emotional regulation.
Doctors often include brain stimulation within a broader mental health treatment strategy that may also involve psychotherapy adjunct care, depression management, and long term relapse prevention planning.
How do doctors measure the success rate of TMS treatment?
Doctors evaluate the success rate of TMS by measuring symptom reduction with standardized rating scales throughout the treatment course. Researchers track outcome measures such as responder rate, remission rate, recovery rate, and overall patient satisfaction.
A positive clinical benefit may include half symptom improvement or achieving minimal symptoms after therapy. These effectiveness studies help determine treatment success, therapeutic response, and long term depression recovery in patients with major depressive disorder.
References
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10856385/
- https://pubmed.ncbi.nlm.nih.gov/30917990/Â